TGFB1 and squamous cell carcinoma: Squamous cell carcinoma (SCC) of skin and keratoacanthoma were potentially TGF-β–mediated cutaneous events [9–11] and occurred in 4% and 8% of patients treated with bintrafusp alfa, with 2% and <1% being grade 3 or worse in severity [12].